Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid Cancer.

Su X, Wang W, Ruan G, Liang M, Zheng J, Chen Y, Wu H, Fahey TJ, Guan M, Teng L.

Int J Mol Sci. 2016 Oct 10;17(10). pii: E1594.

2.

Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer.

Kalsbeek AM, Chan EF, Grogan J, Petersen DC, Jaratlerdsiri W, Gupta R, Lyons RJ, Haynes AM, Horvath LG, Kench JG, Stricker PD, Hayes VM.

Aging (Albany NY). 2016 Oct 5;8(11):2702-2712. doi: 10.18632/aging.101044.

3.

The rise of mitochondria in medicine.

Picard M, Wallace DC, Burelle Y.

Mitochondrion. 2016 Sep;30:105-16. doi: 10.1016/j.mito.2016.07.003. Epub 2016 Jul 14. Review.

4.

A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma.

Calabrese FM, Clima R, Pignataro P, Lasorsa VA, Hogarty MD, Castellano A, Conte M, Tonini GP, Iolascon A, Gasparre G, Capasso M.

Oncotarget. 2016 Aug 2;7(31):49246-49258. doi: 10.18632/oncotarget.10271.

5.

Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension.

Farha S, Hu B, Comhair S, Zein J, Dweik R, Erzurum SC, Aldred MA.

PLoS One. 2016 May 25;11(5):e0156042. doi: 10.1371/journal.pone.0156042. eCollection 2016.

6.

No Association between the Mitochondrial Genome and Prostate Cancer Risk: The Multiethnic Cohort.

Giorgi EE, Li Y, Caberto CP, Beckman KB, Lum-Jones A, Haiman CA, Le Marchand L, Stram DO, Saxena R, Cheng I.

Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):1001-3. doi: 10.1158/1055-9965.EPI-16-0111. Epub 2016 Mar 28.

7.

Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents.

Modica-Napolitano JS, Weissig V.

Int J Mol Sci. 2015 Jul 29;16(8):17394-421. doi: 10.3390/ijms160817394. Review.

8.

Mitochondrial A12308G alteration in tRNA(Leu(CUN)) in colorectal cancer samples.

Mohammed F, Rezaee Khorasany AR, Mosaieby E, Houshmand M.

Diagn Pathol. 2015 Jul 19;10:115. doi: 10.1186/s13000-015-0337-6.

9.

mtDNA germ line variation mediated ROS generates retrograde signaling and induces pro-cancerous metabolic features.

Singh RK, Srivastava A, Kalaiarasan P, Manvati S, Chopra R, Bamezai RN.

Sci Rep. 2014 Oct 10;4:6571. doi: 10.1038/srep06571.

10.

Fatty acids in energy metabolism of the central nervous system.

Panov A, Orynbayeva Z, Vavilin V, Lyakhovich V.

Biomed Res Int. 2014;2014:472459. doi: 10.1155/2014/472459. Epub 2014 May 4. Review.

11.

Mitochondrial DNA haplogroups and susceptibility to prostate cancer in a colombian population.

Cano D, Gomez CF, Ospina N, Cajigas JA, Groot H, Andrade RE, Torres MM.

ISRN Oncol. 2014 Jan 28;2014:530675. doi: 10.1155/2014/530675. eCollection 2014.

12.

Mitochondrial DNA haplogroup confers genetic susceptibility to nasopharyngeal carcinoma in Chaoshanese from Guangdong, China.

Hu SP, Du JP, Li DR, Yao YG.

PLoS One. 2014 Jan 31;9(1):e87795. doi: 10.1371/journal.pone.0087795. eCollection 2014.

13.

mtDNA Mutations and Their Role in Aging, Diseases and Forensic Sciences.

Zapico SC, Ubelaker DH.

Aging Dis. 2013 Oct 3;4(6):364-80. doi: 10.14336/AD.2013.0400364. Review.

14.

Mitochondria and cancer: past, present, and future.

Verschoor ML, Ungard R, Harbottle A, Jakupciak JP, Parr RL, Singh G.

Biomed Res Int. 2013;2013:612369. doi: 10.1155/2013/612369. Epub 2013 Jan 28. Review.

15.

Mitochondrial haplogroups and polymorphisms reveal no association with sporadic prostate cancer in a southern European population.

Álvarez-Cubero MJ, Saiz Guinaldo M, Martínez-González LJ, Álvarez Merino JC, Cózar Olmo JM, Acosta JA.

PLoS One. 2012;7(7):e41201. doi: 10.1371/journal.pone.0041201. Epub 2012 Jul 17.

16.

Mitochondrial regulation of epigenetics and its role in human diseases.

Minocherhomji S, Tollefsbol TO, Singh KK.

Epigenetics. 2012 Apr;7(4):326-34. doi: 10.4161/epi.19547. Epub 2012 Apr 1. Review.

17.

Mitochondrial haplogroups, control region polymorphisms and malignant melanoma: a study in middle European Caucasians.

Ebner S, Lang R, Mueller EE, Eder W, Oeller M, Moser A, Koller J, Paulweber B, Mayr JA, Sperl W, Kofler B.

PLoS One. 2011;6(12):e27192. doi: 10.1371/journal.pone.0027192. Epub 2011 Dec 9.

18.

Mitochondrial DNA sequence variation and risk of pancreatic cancer.

Lam ET, Bracci PM, Holly EA, Chu C, Poon A, Wan E, White K, Kwok PY, Pawlikowska L, Tranah GJ.

Cancer Res. 2012 Feb 1;72(3):686-95. doi: 10.1158/0008-5472.CAN-11-1682. Epub 2011 Dec 15.

19.

The awakening of an advanced malignant cancer: an insult to the mitochondrial genome.

Cook CC, Higuchi M.

Biochim Biophys Acta. 2012 May;1820(5):652-62. doi: 10.1016/j.bbagen.2011.08.017. Epub 2011 Sep 2. Review.

20.

Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.

Permuth-Wey J, Chen YA, Tsai YY, Chen Z, Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, Fridley BL, Sutphen R, McLaughlin J, Narod SA, Goode EL, Schildkraut JM, Fenstermacher D, Phelan CM, Sellers TA.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1131-45. doi: 10.1158/1055-9965.EPI-10-1224. Epub 2011 Mar 29.

Supplemental Content

Support Center